THE MERCK MANUAL: The Merck Manual of Diagnosis and Therapy
Print Topic

Sections

Chapters

Overview of Seronegative Spondyloarthropathies

-
-

Seronegative spondyloarthropathies share certain clinical characteristics (eg, back pain, uveitis, GI symptoms, rashes). Some are strongly associated with the HLA-B27 allele. Clinical and genetic similarities suggest that they also share similar causes or pathophysiologies. Rheumatoid factor (RF) is usually negative in the spondyloarthropathies (hence, why they are called seronegative spondyloarthropathies). They include ankylosing spondylitis (see Joint Disorders: Anklyosing Spondylitis), reactive arthritis (see Joint Disorders: Reactive Arthritis), psoriatic arthritis (see Joint Disorders: Psoriatic Arthritis), and other disorders.

Spondyloarthropathy can develop in association with GI conditions (sometimes called enteropathic arthritis) such as inflammatory bowel disease, intestinal bypass surgery, or Whipple disease.

Juvenile-onset spondyloarthropathy is an asymmetric, mostly lower extremity spondyloarthropathy that begins most commonly in boys aged 7 to 16.

Spondyloarthropathy can also develop in people without characteristics of other specific spondyloarthropathy (undifferentiated spondyloarthropathy). Treatment of the arthritis of these other spondyloarthropathies is similar to that of treatment of reactive arthritis (see Joint Disorders: Reactive Arthritis).

Last full review/revision November 2012 by Roy D. Altman, MD

Copyright     © 2010-2013 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.    Privacy    Terms of Use